Local and Global Resting State Activity in the Noradrenergic and Dopaminergic Pathway Modulated by Reboxetine and Amisulpride in Healthy Subjects

Background: Various psychiatric populations are currently investigated with resting state fMRI, with the aim of individualizing diagnostics and treatment options and improving treatment outcomes. Many of these studies are conducted in large naturalistic samples, providing rich insights regarding disease-related neural alterations, but with the common psychopharmacological medication limiting interpretations of the results. We therefore investigated the effects of common noradrenergic and anti-dopaminergic medications on local and global resting state activity (rs-activity) in healthy volunteers to further the understanding of the respective effects independent from disease-related alterations. Methods: Within a randomized, double-blind, placebo-controlled crossover design, we investigated 19 healthy male subjects by resting state fMRI after the intake of reboxetine (4mg/d), amisulpride (200mg/d), and placebo for 7 days each. Treatment-related differences in local and global rs-activity were measured by the fractional amplitude of low frequency fluctuations (fALFF) and resting state functional connectivity (rs-FC). Results: fALFF revealed alterations of local rs-activity within regions of the core noradrenergic pathway, including the locus coeruleus under reboxetine, correlated with its plasma levels. Moreover, reboxetine led to increased rs-FC between regions within this pathway, i.e. the locus coeruleus, tectum, thalamus, and amygdala. Amisulpride modulated local rs-activity of regions within the dopaminergic pathway, with the altered signal in the putamen correlating with amisulpride plasma levels. Correspondingly, amisulpride increased rs-FC between regions of the dopaminergic pathway comprising the substantia nigra and putamen. Conclusion: Our data provide evidence of how psychopharmacological agents alter local and global rs-activity within the respective neuroanatomical pathways in healthy subjects, which may help with interpreting data in psychiatric populations.

[1]  Anissa Abi-Dargham,et al.  The dopamine dysfunction in schizophrenia revisited: new insights into topography and course. , 2012, Handbook of experimental pharmacology.

[2]  Wayne C. Drevets,et al.  Neuroreceptor imaging in depression , 2013, Neurobiology of Disease.

[3]  Paul M. Grasby,et al.  Systemic sulpiride modulates striatal blood flow: relationships to spatial working memory and planning , 2003, NeuroImage.

[4]  Frank Baumann,et al.  The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory , 2009, Psychopharmacology.

[5]  D J Sanger,et al.  Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. , 1997, The Journal of pharmacology and experimental therapeutics.

[6]  Bryon A. Mueller,et al.  A preliminary study of functional connectivity in comorbid adolescent depression , 2009, Neuroscience Letters.

[7]  G. Fink,et al.  Noradrenergic-glucocorticoid modulation of emotional memory encoding in the human hippocampus , 2011, Psychological Medicine.

[8]  W. K. Simmons,et al.  Circular analysis in systems neuroscience: the dangers of double dipping , 2009, Nature Neuroscience.

[9]  L. Callado,et al.  In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by α2-adrenoceptor antagonism , 2010, European Neuropsychopharmacology.

[10]  D. Schacter,et al.  The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.

[11]  L. Pani,et al.  Consensus on the Use of Substituted Benzamides in Psychiatric Patients , 2004, Neuropsychobiology.

[12]  David K. Grandy,et al.  The Dopamine D2 Receptor , 1992 .

[13]  G H Glover,et al.  Image‐based method for retrospective correction of physiological motion effects in fMRI: RETROICOR , 2000, Magnetic resonance in medicine.

[14]  J. Hsu,et al.  Does the dopamine hypothesis explain schizophrenia? , 2013, Reviews in the neurosciences.

[15]  S. Caccia,et al.  Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize α2‐adrenoceptors in the prefrontal cortex , 2001, British journal of pharmacology.

[16]  S. Kety,et al.  Biogenic Amines and Emotion , 1967, Science.

[17]  M. Breakspear,et al.  Changes in Community Structure of Resting State Functional Connectivity in Unipolar Depression , 2012, PloS one.

[18]  I. Lucki,et al.  Effects of Acute and Chronic Reboxetine Treatment on Stress-induced Monoamine Efflux in the Rat Frontal Cortex , 2002, Neuropsychopharmacology.

[19]  E. Smeraldi.  Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study. , 1998, Journal of affective disorders.

[20]  Jared A. Nielsen,et al.  Multisite functional connectivity MRI classification of autism: ABIDE results , 2013, Front. Hum. Neurosci..

[21]  Yogesh K. Dwivedi.  Noradrenergic Dysfunction in Depression and Suicide -- The Neurobiological Basis of Suicide , 2012 .

[22]  Catie Chang,et al.  Effects of model-based physiological noise correction on default mode network anti-correlations and correlations , 2009, NeuroImage.

[23]  C. Nemeroff,et al.  The role of dopamine in the pathophysiology of depression. , 2007, Archives of general psychiatry.

[24]  M. D’Esposito,et al.  An Approach for Identifying Brainstem Dopaminergic Pathways Using Resting State Functional MRI , 2014, PloS one.

[25]  Ciara McCabe,et al.  Antidepressant medications reduce subcortical–cortical resting-state functional connectivity in healthy volunteers , 2011, NeuroImage.

[26]  Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study , 2002, International clinical psychopharmacology.

[27]  E. Szabadi.  Functional neuroanatomy of the central noradrenergic system , 2013, Journal of psychopharmacology.

[28]  Kristina M. Visscher,et al.  Ventral Tegmental Area/Midbrain Functional Connectivity and Response to Antipsychotic Medication in Schizophrenia , 2014, Neuropsychopharmacology.

[29]  R Cameron Craddock,et al.  Disease state prediction from resting state functional connectivity , 2009, Magnetic resonance in medicine.

[30]  M. Raichle,et al.  Resting State Functional Connectivity in Preclinical Alzheimer’s Disease , 2013, Biological Psychiatry.

[31]  R. Cameron Craddock,et al.  Clinical applications of the functional connectome , 2013, NeuroImage.

[32]  B. Biswal,et al.  Functional connectivity in the motor cortex of resting human brain using echo‐planar mri , 1995, Magnetic resonance in medicine.

[33]  B. Abler,et al.  SSRI-Related Modulation of Sexual Functioning is Predicted by Pre-treatment Resting State Functional Connectivity in Healthy Men , 2013, Archives of sexual behavior.

[34]  N. Volkow,et al.  Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress. , 2007, Nuclear medicine and biology.

[35]  O. Speck,et al.  High Field fMRI Reveals Thalamocortical Integration of Segregated Cognitive and Emotional Processing in Mediodorsal and Intralaminar Thalamic Nuclei , 2010, Front. Neuroanat..

[36]  A. Lowe,et al.  Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging , 2011, Psychopharmacology.

[37]  D. Fage,et al.  Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat , 1997, Brain Research.

[38]  Paul S. Morgan,et al.  In vivo mapping of the human locus coeruleus , 2009, NeuroImage.

[39]  Yufeng Zang,et al.  DPARSF: A MATLAB Toolbox for “Pipeline” Data Analysis of Resting-State fMRI , 2010 .

[40]  Joaquim Radua,et al.  Meta-analysis of functional network alterations in Alzheimer's disease: Toward a network biomarker , 2013, Neuroscience & Biobehavioral Reviews.

[41]  J. Jonides,et al.  Depression, rumination and the default network. , 2011, Social cognitive and affective neuroscience.

[42]  Hans-Jochen Heinze,et al.  Association between heart rate variability and fluctuations in resting-state functional connectivity , 2013, NeuroImage.

[43]  J. Posner,et al.  Connecting the Dots: A Review of Resting Connectivity MRI Studies in Attention-Deficit/Hyperactivity Disorder , 2014, Neuropsychology Review.

[44]  Thomas E. Nichols,et al.  Everything You Never Wanted to Know about Circular Analysis, but Were Afraid to Ask , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  J. Voogd,et al.  The Human Central Nervous System , 1978, Springer Berlin Heidelberg.

[46]  G. Ordway,et al.  Noradrenergic Dysfunction in Depression and Suicide , 2012 .

[47]  Lutz Jäncke,et al.  Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants , 2011, Psychopharmacology.

[48]  P. Delgado,et al.  Role of norepinephrine in depression. , 2000, The Journal of clinical psychiatry.

[49]  Martin Walter,et al.  Neural Correlates of Erotic Stimulation under Different Levels of Female Sexual Hormones , 2013, PloS one.

[50]  G. Perrault,et al.  Amisulpride: from animal pharmacology to therapeutic action , 1997, International clinical psychopharmacology.

[51]  P. Fitzgerald.  Is elevated norepinephrine an etiological factor in some cases of schizophrenia? , 2014, Psychiatry Research.

[52]  S. Kapur,et al.  Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. , 2012, Archives of general psychiatry.

[53]  M. Schölvinck,et al.  Neural basis of global resting-state fMRI activity , 2010, Proceedings of the National Academy of Sciences.

[54]  J. Price,et al.  Neural circuits underlying the pathophysiology of mood disorders , 2012, Trends in Cognitive Sciences.

[55]  B. Bogerts,et al.  Local cortical thinning links to resting-state disconnectivity in major depressive disorder , 2013, Psychological Medicine.

[56]  M. Walter,et al.  Functional mapping of thalamic nuclei and their integration into cortico-striatal-thalamo-cortical loops via ultra-high resolution imaging—from animal anatomy to in vivo imaging in humans , 2013, Front. Neurosci..

[57]  J S Fowler,et al.  Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. , 1994, The American journal of psychiatry.

[58]  Huiguang He,et al.  Glutamatergic and Resting-State Functional Connectivity Correlates of Severity in Major Depression – The Role of Pregenual Anterior Cingulate Cortex and Anterior Insula , 2010, Front. Syst. Neurosci..

[59]  E. Wong,et al.  The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. , 2006, CNS drug reviews.

[60]  L. Radloff.  The CES-D Scale , 1977 .

[61]  Xi-Nian Zuo,et al.  REST: A Toolkit for Resting-State Functional Magnetic Resonance Imaging Data Processing , 2011, PloS one.

[62]  S. Montgomery.  Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders. , 2002, International clinical psychopharmacology.

[63]  K. Chergui,et al.  Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. , 1997, The Journal of pharmacology and experimental therapeutics.

[64]  Silvio Garattini,et al.  Role of presynaptic α2-adrenoceptors in antidepressant action: recent findings from microdialysis studies , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[65]  Chaozhe Zhu,et al.  An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: Fractional ALFF , 2008, Journal of Neuroscience Methods.

[66]  B. Abler,et al.  Modulation of Frontostriatal Interaction Aligns with Reduced Primary Reward Processing under Serotonergic Drugs , 2012, The Journal of Neuroscience.

[67]  Daniella J. Furman,et al.  Default-Mode and Task-Positive Network Activity in Major Depressive Disorder: Implications for Adaptive and Maladaptive Rumination , 2011, Biological Psychiatry.

[68]  B. Abler,et al.  Erotic Stimulus Processing under Amisulpride and Reboxetine: A Placebo-Controlled fMRI Study in Healthy Subjects , 2015, The international journal of neuropsychopharmacology.

[69]  D R Medoff,et al.  Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. , 1996, The American journal of psychiatry.

[70]  H. Möller,et al.  D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[71]  Hans-Georg Buchholz,et al.  High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia. , 2004, The international journal of neuropsychopharmacology.

[72]  Mark S. Cohen,et al.  Decreased small-world functional network connectivity and clustering across resting state networks in schizophrenia: an fMRI classification tutorial , 2013, Front. Hum. Neurosci..

[73]  B. Abler,et al.  Effects of amisulpride on human resting cerebral perfusion , 2013, Psychopharmacology.

[74]  B. Abler,et al.  Neural Correlates of Antidepressant-Related Sexual Dysfunction: A Placebo-Controlled fMRI Study on Healthy Males Under Subchronic Paroxetine and Bupropion , 2011, Neuropsychopharmacology.

[75]  M. Page.  The promises and pitfalls of reboxetine. , 2006, CNS drug reviews.

[76]  J. Ford,et al.  Default mode network activity and connectivity in psychopathology. , 2012, Annual review of clinical psychology.

[77]  G. Glover,et al.  Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus , 2007, Biological Psychiatry.

[78]  Henrik Walter,et al.  Noradrenergic enhancement of amygdala responses to fear. , 2009, Social cognitive and affective neuroscience.

[79]  Chaogan Yan,et al.  DPARSF: A MATLAB Toolbox for “Pipeline” Data Analysis of Resting-State fMRI , 2010, Front. Syst. Neurosci..

[80]  B. Abler,et al.  Modulation of attention network activation under antidepressant agents in healthy subjects. , 2013, The international journal of neuropsychopharmacology.